Literature DB >> 28210920

Choosing the appropriate side for subcutaneous port catheter placement in patients with mastectomy: ipsilateral or contralateral?

Omer Fatih Nas1, Kadir Hacikurt2, Ahmet Kaya3, Nurullah Dogan4, Bekir Sanal5, Guven Ozkaya6, Halit Ziya Dundar7, Cuneyt Erdogan3.   

Abstract

PURPOSE: To evaluate long-term clinical follow-up results of implanting subcutaneous port catheters (SPCs) on ipsilateral or contralateral with mastectomy side in patients with axillary lymph node dissection.
METHODS: A total of 73 patients composed of ipsilateral (34 catheters) and contralateral (39 catheters) groups, with SPCs were included. All patients had lumpectomy or modified radical mastectomy for breast cancer. Ipsilateral and contralateral groups had similar patient characteristics.
RESULTS: Five late complications were seen in the ipsilateral group and 2 late complications in the contralateral group. No statistical significant difference was seen between two groups in regard to late complications. Four complications of the ipsilateral group were classified as major group C and 1 as major group D, while 1 complication of the contralateral group was classified as minor group B and 1 as major group C according to Society of Interventional Radiology (SIR) classification. No statistical significant difference was seen between complication rates of two groups in regard to SIR classification.
CONCLUSIONS: SPC related complications do not differ in regard to ipsilateral or contralateral side selection on mastectomized patients with breast cancer and lymph node dissection. SPCs can be implanted on ipsilateral or contralateral sides of the operation in these patients.

Entities:  

Keywords:  Breast cancer; Contralateral; Ipsilateral; Society of interventional radiology; Subcutaneous port catheter

Mesh:

Year:  2017        PMID: 28210920     DOI: 10.1007/s11547-017-0736-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  17 in total

1.  Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.

Authors:  H Lorch; M Zwaan; C Kagel; H D Weiss
Journal:  Cardiovasc Intervent Radiol       Date:  2001 May-Jun       Impact factor: 2.740

Review 2.  Reporting standards for central venous access.

Authors:  James E Silberzweig; David Sacks; Azita S Khorsandi; Curtis W Bakal
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

3.  Management and prevention of complications of subcutaneous intravenous infusion port.

Authors:  Hsiang-Chun Jan; Shao-Jiun Chou; Tzu-Hung Chen; Chuin-I Lee; Tze-Kai Chen; Mary Ann Lou
Journal:  Surg Oncol       Date:  2010-07-31       Impact factor: 3.279

4.  A trial with a new peripheral implanted vascular access device.

Authors:  V Winters; B Peters; S Coilá; L Jones
Journal:  Oncol Nurs Forum       Date:  1990 Nov-Dec       Impact factor: 2.172

5.  Subcutaneous venous port implantation in patients with bilateral breast surgery.

Authors:  Bora Peynircioglu; E Bengi Arslan; Barbaros E Cil; Serdar Geyik; Tuncay Hazirolan; Ali Konan; Ferhun Balkanci
Journal:  Cardiovasc Intervent Radiol       Date:  2007 May-Jun       Impact factor: 2.740

Review 6.  Role of lymphoscintigraphy for selective sentinel lymphadenectomy.

Authors:  Roger F Uren; Robert B Howman-Giles; David Chung; John F Thompson
Journal:  Cancer Treat Res       Date:  2005

7.  Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

Authors:  R Biffi; F de Braud; F Orsi; S Pozzi; S Mauri; A Goldhirsch; F Nolè; B Andreoni
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

8.  Complications related to indwelling caval catheters on a gynecologic oncology service.

Authors:  D F Silver; R E Hempling; F O Recio; M S Piver; G H Eltabbakh
Journal:  Gynecol Oncol       Date:  1998-09       Impact factor: 5.482

Review 9.  Precipitating factors in lymphedema: myths and realities.

Authors:  S G Rockson
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

Review 10.  Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature.

Authors:  J Vardy; K Engelhardt; K Cox; J Jacquet; A McDade; M Boyer; P Beale; M Stockler; R Loneragan; B Dennien; R Waugh; S J Clarke
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more
  1 in total

1.  Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice.

Authors:  Feng Ye; Yubo Liu; Ping Yu; Na Li; Yan Wang; Xiaoming Xie; Jun Tang
Journal:  Cancer Med       Date:  2020-11-04       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.